Abstract
ObjectiveIn patients with Crohn’s disease (CD) on combination therapy (infliximab and immunosuppressant) and stopping infliximab (cohort from the study of infliximab diSconTinuation in CrOhn’s disease patients in stable Remission on...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have